Results 31 to 40 of about 107,646 (331)

Blood product transfusion in emergency department patients: A case-control study of practice patterns and impact on outcome [PDF]

open access: yes, 2017
Definitions of comorbid conditions.
Beyer, Alexander   +4 more
core   +3 more sources

Clinical observation of factors in the efficacy of blood component transfusion in patients following hematopoietic stem cell transplantation. [PDF]

open access: yesPLoS ONE, 2012
BACKGROUND: Factors affecting the efficacy of platelet and red blood cell (RBC) transfusion in patients undergoing hematopoietic stem cell transplantation (HSCT) have not been studied extensively.
Xi Zhang   +7 more
doaj   +1 more source

Demand Forecasting for Platelet Usage: from Univariate Time Series to Multivariate Models [PDF]

open access: yesarXiv, 2021
Platelet products are both expensive and have very short shelf lives. As usage rates for platelets are highly variable, the effective management of platelet demand and supply is very important yet challenging. The primary goal of this paper is to present an efficient forecasting model for platelet demand at Canadian Blood Services (CBS).
arxiv  

Evaluation of Changes in Platelet Level and Influenced Factors in Patients with Thrombocytopenia

open access: yesمجله دانشکده پزشکی اصفهان, 2018
Background: Hemostasis is a hemodynamic process in which the platelet play a major role. Platelet transfusion is one of the effective treatments in patients with thrombocytopenia, which has been increased during the recent decades.
Babak Alikiaii, Sahar Dashti
doaj   +1 more source

Dose- and time-related platelet response with apheresis platelet concentrates and pooled platelets

open access: yesBangabandhu Sheikh Mujib Medical University Journal, 2017
This study was carried out to compare the post-transfusion platelet increment between the apheresis platelet concentrate (n=74) and pooled platelets (n=54).
Mohammad Mizanur Rahman   +2 more
doaj   +1 more source

Detection of platelet antibody and evaluation of platelet transfusion efficacy in patients with hematologic disease

open access: yesZhongguo shuxue zazhi, 2022
Objective To investigate the factors influencing the production of platelet antibody and its effect on clinical platelet transfusion. Methods This is a single-center prospective observational study.
Qianwen SHANG   +4 more
doaj   +1 more source

Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study

open access: yesBMC Gastroenterology, 2020
Background Chronic liver disease (CLD) is often complicated by severe thrombocytopenia (platelet count  50,000/µL at baseline: the proportions of patients who did not require platelet transfusion were 84–96%, which might be overestimated.
Hiroaki Nomoto   +11 more
doaj   +1 more source

Immersed boundary simulations of cell-cell interactions in whole blood [PDF]

open access: yes, 2021
We present a new method for the geometric reconstruction of elastic surfaces simulated by the immersed boundary method with the goal of simulating the motion and interactions of cells in whole blood. Our method uses parameter-free radial basis functions for high-order meshless parametric reconstruction of point clouds and the elastic force computations
arxiv   +1 more source

Effects of hemoglobin-based oxygen carriers on blood coagulation. [PDF]

open access: yes, 2014
For many decades, Hemoglobin-based oxygen carriers (HBOCs) have been central in the development of resuscitation agents that might provide oxygen delivery in addition to simple volume expansion.
Holtby, Randall J   +2 more
core   +3 more sources

All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD [PDF]

open access: yes, 2011
Variant CJD (vCJD) is an incurable, infectious human disease, likely arising from the consumption of BSE-contaminated meat products. Whilst the epidemic appears to be waning, there is much concern that vCJD infection may be perpetuated in humans by the ...
AH Peden   +64 more
core   +3 more sources

Home - About - Disclaimer - Privacy